The Federal Trade Commission announced a joint warning letter issued with the U.S. Food and Drug Administration (FDA) to Rooted Apothecary, LLC for selling products containing cannabidiol (CBD) online with potentially unsubstantiated claims that the products can treat autism, attention-deficit/hyperactivity disorder (ADHD), as well as Parkinson’s and Alzheimer’s, among other conditions.
Under the FTC Act, it is unlawful to advertise that a product can prevent, treat, or cure human disease unless the seller has competent and reliable scientific evidence substantiating that the claims are true when made. The letter states that the Commission is concerned that “one or more of the efficacy claims [the company made] may not be substantiated by competent and reliable scientific evidence.”
As described in the letter, the Florida-based company used product web pages and its online store and social media websites to make many heath and efficacy claims about several of its CBD products. Examples include:
The FTC has asked Rooted Apothecary to review the ads and respond within 15 working days stating how the company will address the FTC’s concerns. Violations of the FTC Act may result in legal action seeking a federal district court injunction or administrative cease and desist order, and an order also may require that a company pay back money to consumers. (The staff contact is Richard Cleland, Bureau of Consumer Protection, 202‑326‑3088.)
The Federal Trade Commission works to promote competition, and protect and educate consumers. You can learn more about consumer topics and file a consumer complaint online or by calling 1-877-FTC-HELP (382-4357). Like the FTC on Facebook, follow us on Twitter, read our blogs, and subscribe to press releases for the latest FTC news and resources.
WASHINGTON – Today, the U.S. Department of the Treasury (Treasury), as Chair of the Committee…
WASHINGTON—Today, the U.S. Department of the Treasury’s Community Development Financial Institutions Fund (CDFI Fund) and…
Washington – The findings from the annual survey of U.S. portfolio holdings of foreign securities…
WASHINGTON – The U.S. Department of the Treasury hosted a roundtable on October 30 with…
WASHINGTON – The United States and the People’s Republic of China held the sixth meeting…
WASHINGTON — Today, the Department of the Treasury’s Office of Foreign Assets Control (OFAC) sanctioned…